Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Inv. presentation

BICYCLE THERAPEUTICS plc (BCYC) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 Thompson Travis Alvin (Chief Accounting Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 54 shares @ $20, valued at $1.1k
10/05/2023 4 Keen Nicholas (Chief Scientific Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 272 shares @ $20, valued at $5.4k
10/05/2023 4 Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 442 shares @ $20, valued at $8.8k
10/05/2023 4 Milnes Alistair (COO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 442 shares @ $20, valued at $8.8k
10/05/2023 4 Lee Kevin (CEO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 1,470 shares @ $20, valued at $29.4k
10/05/2023 4 Skynner Michael (Chief Technology Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 442 shares @ $20, valued at $8.8k
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update"
07/19/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/13/2023 8-K Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Other Events, Financial Statements...
Docs: "Bicycle Therapeutics plc 4,705,884 American Depositary Shares representing 4,705,884 Ordinary Shares, nominal value £0.01 per share 4,705,882 Non-Voting Ordinary Shares, nominal value £0.01 per share",
"Description of the Non-Voting Ordinary Shares",
"Granta Park, Great Abington"
07/13/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/12/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
07/06/2023 4 Thompson Travis Alvin (Chief Accounting Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 61 shares @ $25.1, valued at $1.5k
07/06/2023 4 Skynner Michael (Chief Technology Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 451 shares @ $25.1, valued at $11.3k
07/06/2023 4 Milnes Alistair (COO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 451 shares @ $25.1, valued at $11.3k
07/06/2023 4 Lee Kevin (CEO) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 1,498 shares @ $25.1, valued at $37.6k
07/06/2023 4 Keen Nicholas (Chief Scientific Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 336 shares @ $25.1, valued at $8.4k
07/06/2023 4 Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 451 shares @ $25.1, valued at $11.3k
07/03/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
07/03/2023 144 Form 144 - Report of proposed sale of securities:
05/26/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Opinion of Cooley (UK) LLP"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy